Home › Studies › PRJNA1479378
PRJNA1479378 SRP710669

Gut microbiota, bile acids, and acute GvHD after HCT

Gut microbiota and graft versus host disease

245 stool samples from a longitudinal case-control study of allogeneic hematopoietic cell transplant recipients with and without acute gut graft-versus-host disease, examining gut microbiome and bile acid metabolism. machine-written summary

245 samples · 245 runs · US · Age unknown · 2026 · 8.13 Gbp / sample

Sources
✓Sequence archive 1,225✓Abstract / description 245✓Full text 490○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,225 sample values (country, location locality, location region, subject id, timepoint)
✓ Abstract / description245 sample values (health condition detail)
✓ Full text490 sample values (collection date, location site) · PMC13391574
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
unknown245
Country
US245
Body site
primary245
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 1 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 1 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 2 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 7 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 15 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 136 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 80 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 3 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 8.13 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

83 of 98 people sampled more than once (230 samples; median 3, up to 3 per person). Schedule stated by the source: “Stool collected at three time points: pre-transplant, day 30 post-transplant, day 60 post-transplant (±7 days)” (time origin: transplant); stated follow-up 2 mo.

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country245 100%245
health_condition0 0%
subject_id245 100%245
collection_date245 100%245
detailed_location245 100%
health_condition_detail245 100%245
location_locality245 100%245
location_region245 100%245
location_site245 100%245
timepoint_label245 100%245
Papers (1)
  • Acute gastrointestinal graft-versus-host disease is associated with reductions of secondary bile acids following allogeneic hematopoietic cell transplantation. 2026 PMID 42495148 PMC13391574 own_data
Details
Archive description

The Project examines the role of bile acids and the gut microbiota in graft versus host disease

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.68. Assay shotgun_dna.

  • host study.description · “gut microbiota in graft versus host disease”
  • body site study.title · “Gut microbiota and graft versus host disease”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN60991134collection_date2013-04/2020-03R30.70paper.fulltext.methodsbetween April 2013 and March 2020
SAMN60991134countryUSR10.90sample.attr.geo_loc_nameUSA: Seattle, WA
SAMN60991134health_condition_detailmixed_case_control: acute gastrointestinal graft-versus-host disease patients vs controls without GvHDR40.50paper.abstractpatients with and without acute gut GvHD
SAMN60991134location_localitySeattleR10.85biosample.attribute:geo_loc_nameUSA: Seattle, WA
SAMN60991134location_regionWashingtonR10.75biosample.attribute:geo_loc_nameUSA: Seattle, WA
SAMN60991134location_siteFred Hutchinson Cancer CenterR30.70paper.fulltext.methodsallogeneic HCT at the Fred Hutchinson Cancer Center in Seattle, WA
SAMN60991134subject_id001R10.70sample.name_rule:unique_sample_namewgs_part_001_01
SAMN60991134timepoint_label01R10.70sample.name_rule:unique_sample_namewgs_part_001_01
Sequencing

245 runs over 245 samples · mean 9.54 Gbp per run (median 8.13 Gbp, total 2,337.17 Gbp; 245 runs with a base count) · layout PAIRED 245 · platform ILLUMINA 245 · models Illumina NovaSeq 6000 (245) · 0% of runs with a Sandpiper profile · first public 2026-06-19 – 2026-06-20

Authors (15)

Cagle R first · Proll S · Minot SS · Purcell H · Zhu W · Djukovic D · Liu C · Fiedler T · DeMeules M · Mielcarek M · Srinivasan S · Raftery D · Wu M · Pergam SA · Fredricks DN last

Help complete this project

2 of the 4 core fields are below 50% coverage: age_category, health_condition. Share metadata

Downloads

PRJNA1479378.csv.gz (7.2 KB) · parquet (79.5 KB) — all 245 samples, every field with route and confidence · PRJNA1479378_determinations.csv.gz (13.8 KB) — 1,960 evidence rows

Samples (245 · every field this project has values for · hover a cell for its source)
Loading the sample table…